• Return to Headlines

Genmark Diagnost Up 33.3% Since SmarTrend Uptrend Call (GNMK)

By Shiri Gupta

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 9th, 2018 at $5.42. In approximately 5 months, Genmark Diagnost has returned 33.33% as of today's recent price of $7.22.

In the past 52 weeks, shares of Genmark Diagnost have traded between a low of $3.63 and a high of $13.50 and are now at $7.22, which is 99% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 1.7%.

GenMark Diagnostics Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The Company's system supports a broad range of molecular diagnostic tests with a compact workstation and self-contained disposable test cartridges.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Genmark Diagnost shares.

Log in and add Genmark Diagnost (GNMK) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights genmark diagnost

Ticker(s): GNMK